Company Analysis

Zevra Therapeutics, Inc. (ZVRA)

Nasdaq: ZVRA · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2008
Grade5.6
◀ Past 4.5● Present 5.8▶ Future 6.1
1 est.

Filings

449 filings since 2017 beside 276 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 34 days after the quarter ended. The proxy statement was last filed Apr 20, 2026.

Filings a yearinsider forms included
708111447102757154
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Mar 9, 2026.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Mar 28, 2024.SEC letters: 10 in the last 36 months, the newest Apr 17, 2025.
Insider forms 276

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 3, 2026 10-Q Quarterly report Sep 30, 2026
Nov 3, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 6, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 5, 2026 10-Q Quarterly report Jun 30, 2026
Aug 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 31, 2026 SCHEDULE 13G Large holder notice
Jun 5, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Jun 4, 2026
May 6, 2026 10-Q Quarterly report Mar 31, 2026
May 6, 2026 8-K items 2.02, 9.01 Results released · Current report
May 6, 2026 SCHEDULE 13G Large holder notice
Apr 20, 2026 DEF 14A Proxy statement Jun 4, 2026
Apr 6, 2026 PRE 14A Preliminary proxy statement
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 16, 2026 8-K items 1.01, 1.02, 7.01, 9.01 Major agreement signed; Major agreement ended; Investor disclosure (Regulation FD) · Current report Mar 12, 2026
Mar 9, 2026 S-8 Employee stock plan registration
Mar 9, 2026 10-K Annual report Dec 31, 2025
Mar 9, 2026 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report Mar 4, 2026
Dec 17, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Dec 11, 2025
Dec 2, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Nov 26, 2025
Nov 20, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 13, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 5, 2025 10-Q Quarterly report Sep 30, 2025
Nov 5, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 12, 2025 10-Q Quarterly report Jun 30, 2025
Aug 12, 2025 8-K items 2.02, 9.01 Results released · Current report
May 29, 2025 8-K item 5.07 Shareholder vote · Current report
May 21, 2025 DEFA14A Extra proxy material
May 13, 2025 10-Q Quarterly report Mar 31, 2025
May 13, 2025 8-K items 2.02, 9.01 Results released · Current report
May 8, 2025 DEFA14A Extra proxy material
Apr 29, 2025 DEFC14A Contested proxy statement
Apr 24, 2025 PRRN14A Form PRRN14A
Apr 23, 2025 DFAN14A Proxy material from an outside party
Apr 21, 2025 DEFA14A Extra proxy material
Apr 21, 2025 DEFA14A Extra proxy material
Apr 21, 2025 DEFC14A Contested proxy statement
Apr 17, 2025 UPLOAD SEC comment letter
40 of 449 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ZVRA · research, not advice